This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
What does not work: describing how the decision made you feel, however justified. The reviewer is checking criteria and the job is to make them checkable.
Marking that as an opinion rather than a finding.
What would change my mind on Prior authorisation is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.
Confirming post #30 from a second method, which matters more than confirming it from a second person.
The useful distinction on Prior authorisation is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
That is a cleaner way of putting what I was circling around.
Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.
I checked the source rather than the summary, and they differ.
I disagree with the framing of Prior authorisation above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.
The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.
Date every account in this subcategory. Payer criteria change frequently and the archive keeps posts permanently.
I am describing what is, rather than arguing for what should be.
Adding thanks rather than a view. I do not have a view worth the space.
The single most useful preparation is obtaining the actual criteria document rather than working from what somebody was told on the phone.
Coming back to post #41, because the follow-up matters more than the original answer.
Summarising the Prior authorisation thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.
Post #41 is right about the mechanism and I think understates the practical bit.
Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
I keep a log of this specifically because memory is unreliable about it.
Genuine question rather than a rhetorical one: has anyone here actually observed Prior authorisation, as opposed to read about it? The thread is long and I cannot tell.
Picking up post #45: that is the part I would want checked first.
Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying it.
I had written a reply contradicting post #45 and deleted it. Here is what survived.
Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves surprise at the pharmacy.
One more caveat and then I will stop qualifying: the sample selected itself.
Adding a reference point for Prior authorisation. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
Post #45 describes the usual case. This is about the unusual one.
Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
Someone should write this up properly, and it should probably not be me.
Adding the measurement that post #49 says would settle it.
A methods point on Prior authorisation rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
Formulary changes happen on a published schedule, so a denial now may be answering criteria that change shortly.
Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
Two sentences on Prior authorisation and then I will stop, because the rest is speculation and the thread is better without mine.
What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.
I had written a reply contradicting post #50 and deleted it. Here is what survived.
Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
Not a conclusion. A place to stand while looking for one.
The arithmetic in post #52 is right; the assumption feeding it is the part to check.
Reading this Prior authorisation thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want. Understanding the requirements before treatment starts matters.
I will take the caveat as seriously as the claim, which is the point of putting it there.